Sefaxersen (RO7434656)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Sefaxersen (RO7434656), covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression [Phase 3]